Arkolith/Insider Trading/IRD/Form 4

Foundation Fighting Blindness Retinal Degeneration Fund

DirectorOpus Genetics, Inc. (IRD) · full profile →Form 4 · filed Dec 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8.6M
Net Open-Market Flow
-$8.6M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Sell(S)4.0M$2.15$8.6M5.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002042266-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML